Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations - PubMed (original) (raw)
Case Reports
Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations
Sigurd Broesby-Olsen et al. J Allergy Clin Immunol. 2012 Sep.
No abstract available
Similar articles
- KIT D816V and JAK2 V617F mutations are seen recurrently in hypereosinophilia of unknown significance.
Schwaab J, Umbach R, Metzgeroth G, Naumann N, Jawhar M, Sotlar K, Horny HP, Gaiser T, Hofmann WK, Schnittger S, Cross NC, Fabarius A, Reiter A. Schwaab J, et al. Am J Hematol. 2015 Sep;90(9):774-7. doi: 10.1002/ajh.24075. Epub 2015 Aug 14. Am J Hematol. 2015. PMID: 26017288 - Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations.
Naumann N, Lübke J, Shomali W, Reiter L, Horny HP, Jawhar M, Dangelo V, Fabarius A, Metzgeroth G, Kreil S, Sotlar K, Oni C, Harrison C, Hofmann WK, Cross NCP, Valent P, Radia D, Gotlib J, Reiter A, Schwaab J. Naumann N, et al. Br J Haematol. 2021 Jul;194(2):344-354. doi: 10.1111/bjh.17567. Epub 2021 Jun 1. Br J Haematol. 2021. PMID: 34060083 - KIT mutations in mastocytosis and their potential as therapeutic targets.
Gotlib J. Gotlib J. Immunol Allergy Clin North Am. 2006 Aug;26(3):575-92. doi: 10.1016/j.iac.2006.05.003. Immunol Allergy Clin North Am. 2006. PMID: 16931294 Review. - Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.
Pardanani A, Tefferi A. Pardanani A, et al. Curr Opin Hematol. 2010 Mar;17(2):125-32. doi: 10.1097/MOH.0b013e3283366c59. Curr Opin Hematol. 2010. PMID: 20075725 Review.
Cited by
- Comprehensive Analysis of Acquired Genetic Variants and Their Prognostic Impact in Systemic Mastocytosis.
González-López O, Muñoz-González JI, Orfao A, Álvarez-Twose I, García-Montero AC. González-López O, et al. Cancers (Basel). 2022 May 18;14(10):2487. doi: 10.3390/cancers14102487. Cancers (Basel). 2022. PMID: 35626091 Free PMC article. Review. - Systemic Mastocytosis: Multidisciplinary Approach.
Zanotti R, Tanasi I, Crosera L, Bonifacio M, Schena D, Orsolini G, Mastropaolo F, Tebaldi M, Olivieri E, Bonadonna P. Zanotti R, et al. Mediterr J Hematol Infect Dis. 2021 Nov 1;13(1):e2021068. doi: 10.4084/MJHID.2021.068. eCollection 2021. Mediterr J Hematol Infect Dis. 2021. PMID: 34804442 Free PMC article. Review. - Increased TPSAB1 Copy Number in a Family With Elevated Basal Serum Levels of Tryptase.
Hernández-Hernández L, Sanz C, Marcos-Vadillo E, García-Sánchez A, Moreno E, Lorente F, González-de-Olano D, Dávila I, Isidoro-García M. Hernández-Hernández L, et al. Front Med (Lausanne). 2021 Apr 13;8:577081. doi: 10.3389/fmed.2021.577081. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33928098 Free PMC article. - Impact of somatic and germline mutations on the outcome of systemic mastocytosis.
Muñoz-González JI, Jara-Acevedo M, Alvarez-Twose I, Merker JD, Teodosio C, Hou Y, Henriques A, Roskin KM, Sanchez-Muñoz L, Tsai AG, Caldas C, Matito A, Sánchez-Gallego JI, Mayado A, Dasilva-Freire N, Gotlib JR, Escribano L, Orfao A, García-Montero AC. Muñoz-González JI, et al. Blood Adv. 2018 Nov 13;2(21):2814-2828. doi: 10.1182/bloodadvances.2018020628. Blood Adv. 2018. PMID: 30373888 Free PMC article. - Clinical Validation of KIT Inhibition in Advanced Systemic Mastocytosis.
Baird JH, Gotlib J. Baird JH, et al. Curr Hematol Malig Rep. 2018 Oct;13(5):407-416. doi: 10.1007/s11899-018-0469-3. Curr Hematol Malig Rep. 2018. PMID: 30155614 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous